Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
Medicare Spending Peaks at Age 96

In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses the implications of a Kaiser finding: per capita Medicare spending peaks at age 96, and the main reason is not end-of-life care.

Key Facts: Women and Medicare

Medicare is a critical source of health insurance coverage for virtually all older women in the U.S. and for many younger women who have permanent disabilities. Today, 22 million women one in five adult women rely on Medicare for basic health insurance protection. In fact, women comprise 57% of the…

Improving Prescription Drug Coverage: Opportunities and Challenges for Reform

Tricia Neuman, Vice President and Director of the Medicare Policy Project, testified before the Senate Finance Committee on prescription drug coverage under Medicare. The statement reviews existing sources of prescription drug coverage for Medicare beneficiaries and the importance of such coverage for this population. It reviews current approaches for improving…

The Future of Retiree Health Benefits: Challenges and Options

Tricia Neuman, Vice President and Director of the Medicare Policy Project testified before the House Subcommittee on Employer-Employee Relations on retiree health coverage for older Americans. The statement describes the health needs of aging adults and the importance of health insurance coverage at a time in their lives when they…

Medicare Prescription Drug Coverage: Facts, Options, and Implications

Testimony by Patricia Neuman, Sc.D., vice president and director of the Foundation’s Medicare Policy Project, for the House Committee on Energy and Commerce, Subcommittee on Health, hearing on Creating a Medicare Prescription Drug Benefit: begins with a brief review of existing sources of prescription drug coverage for the Medicare population…

Medicare Cost-Sharing: Implications for Beneficiaries

Tricia Neuman, Vice President and Director of the Medicare Policy Project, testified on behalf of herself and Thomas Rice, Ph.D., of UCLA’s School of Public Health, before the House Ways and Means Subcommittee on Health on cost-sharing requirements under Medicare and supplemental Medigap policies. The statement reviews Medicare beneficiaries’ current…

Medicare Spending Cuts and Hospital Productivity Gains

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman and guest co-author Dana Goldman examine hospital productivity gains, and what they may mean for hospitals’ ability to absorb spending reductions. All previous columns by Drew Altman are available online.

Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs

This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections…

Policy Workshop on Formularies and Medicare

The Kaiser Family Foundation hosted a March 14, 2005 policy workshop on the use of drug formularies in the private sector and their potential implications for beneficiaries under the new Medicare drug benefit, set to go into effect January 1, 2006. The workshop involved an expert panel, including perspectives from…